First Time Loading...

Heidelberg Pharma AG
XETRA:HPHA

Watchlist Manager
Heidelberg Pharma AG Logo
Heidelberg Pharma AG
XETRA:HPHA
Watchlist
Price: 2.98 EUR Market Closed
Updated: May 6, 2024

Heidelberg Pharma AG
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Heidelberg Pharma AG
Revenue Peer Comparison

Comparables:
BNTX
MOR
IMTX
BIO
FYB

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Heidelberg Pharma AG
XETRA:HPHA
Revenue
€9.9m
CAGR 3-Years
5%
CAGR 5-Years
22%
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Revenue
€3.8B
CAGR 3-Years
99%
CAGR 5-Years
97%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Revenue
€238.3m
CAGR 3-Years
-10%
CAGR 5-Years
26%
CAGR 10-Years
12%
Immatics NV
NASDAQ:IMTX
Revenue
€54m
CAGR 3-Years
20%
CAGR 5-Years
70%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Revenue
€684.6m
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
3%
Formycon AG
XETRA:FYB
Revenue
€42.5m
CAGR 3-Years
8%
CAGR 5-Years
8%
CAGR 10-Years
N/A

See Also

What is Heidelberg Pharma AG's Revenue?
Revenue
9.9m EUR

Based on the financial report for Nov 30, 2023, Heidelberg Pharma AG's Revenue amounts to 9.9m EUR.

What is Heidelberg Pharma AG's Revenue growth rate?
Revenue CAGR 5Y
22%

Over the last year, the Revenue growth was -47%. The average annual Revenue growth rates for Heidelberg Pharma AG have been 5% over the past three years , 22% over the past five years .